Antitumor activity of 5-substituted 2-acylamino-1,3,4-thiadiazoles against transplantable rodent tumors. 1985

K Miyamoto, and R Koshiura, and M Mori, and H Yokoi, and C Mori, and T Hasegawa, and K Takatori

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013830 Thiadiazoles Heterocyclic compounds composed of a five-membered heterocyclic ring which contains one sulfur and two nitrogen atoms. Thiadiazole
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

K Miyamoto, and R Koshiura, and M Mori, and H Yokoi, and C Mori, and T Hasegawa, and K Takatori
December 1982, Chemical & pharmaceutical bulletin,
K Miyamoto, and R Koshiura, and M Mori, and H Yokoi, and C Mori, and T Hasegawa, and K Takatori
February 2011, Journal of enzyme inhibition and medicinal chemistry,
K Miyamoto, and R Koshiura, and M Mori, and H Yokoi, and C Mori, and T Hasegawa, and K Takatori
April 2006, European journal of medicinal chemistry,
K Miyamoto, and R Koshiura, and M Mori, and H Yokoi, and C Mori, and T Hasegawa, and K Takatori
November 1986, Journal of medicinal chemistry,
K Miyamoto, and R Koshiura, and M Mori, and H Yokoi, and C Mori, and T Hasegawa, and K Takatori
May 1988, Journal of medicinal chemistry,
K Miyamoto, and R Koshiura, and M Mori, and H Yokoi, and C Mori, and T Hasegawa, and K Takatori
July 2006, Bioorganic & medicinal chemistry,
K Miyamoto, and R Koshiura, and M Mori, and H Yokoi, and C Mori, and T Hasegawa, and K Takatori
January 2022, Scientifica,
K Miyamoto, and R Koshiura, and M Mori, and H Yokoi, and C Mori, and T Hasegawa, and K Takatori
April 2005, Bioorganic & medicinal chemistry letters,
K Miyamoto, and R Koshiura, and M Mori, and H Yokoi, and C Mori, and T Hasegawa, and K Takatori
January 1988, Journal of medicinal chemistry,
K Miyamoto, and R Koshiura, and M Mori, and H Yokoi, and C Mori, and T Hasegawa, and K Takatori
May 1987, Journal of medicinal chemistry,
Copied contents to your clipboard!